Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer.

Published in: Journal of gynecologic oncology (2018)

Continuous low dosage administration of olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer.

Keyphrases